
Company valuation, historical trends, and peer comparisons.
According to Raphael Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 30.51M. This represents a change of 32.18% compared to the average of 23.08M of the last 4 quarters.
The mean historical Enterprise Value of Raphael Pharmaceutical Inc. over the last ten years is 22.78M. The current 30.51M Enterprise Value has changed 33.93% with respect to the historical average. Over the past ten years (40 quarters), RAPH's Enterprise Value was at its highest in in the September 2024 quarter at 30.82M. The Enterprise Value was at its lowest in in the December 2024 quarter at 5.00M.
Average
22.78M
Median
27.36M
Minimum
4.88M
Maximum
33.91M
Discovering the peaks and valleys of Raphael Pharmaceutical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 461.00%
Maximum Annual Enterprise Value = 33.91M
Minimum Annual Increase = -70.42%
Minimum Annual Enterprise Value = 4.88M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 27.36M | 461.00% |
| 2024 | 4.88M | -70.42% |
| 2023 | 16.49M | -47.26% |
| 2022 | 31.26M | -7.81% |
The current Enterprise Value of Raphael Pharmaceutical Inc. (RAPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
16.24M
5-year avg
22.78M
10-year avg
22.78M
Raphael Pharmaceutical Inc.’s Enterprise Value is greater than OWC Pharmaceutical Research Corp. (-3459025.00), greater than InMed Pharmaceuticals Inc. (6.76M), greater than Artelo Biosciences, Inc. (3.59M), greater than Protagenic Therapeutics, Inc. (556.34K), less than Charlotte's Web Holdings, Inc. (61.40M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -3459025.00 | $4.97K | |
| 6.76M | $8.95M | |
| 3.59M | $7.74M | |
| 556.34K | $1.12M | |
| 61.40M | $62.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Raphael Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Raphael Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Raphael Pharmaceutical Inc.'s Enterprise Value?
What is the highest Enterprise Value for Raphael Pharmaceutical Inc. (RAPH)?
What is the 3-year average Enterprise Value for Raphael Pharmaceutical Inc. (RAPH)?
What is the 5-year average Enterprise Value for Raphael Pharmaceutical Inc. (RAPH)?
How does the current Enterprise Value for Raphael Pharmaceutical Inc. (RAPH) compare to its historical average?